share_log

Heart Test Laboratories | UPLOAD: Others

Heart Test Laboratories | UPLOAD: Others

Heart Test Laboratories | UPLOAD:其他
美股SEC公告 ·  03/11 12:58

Moomoo AI 已提取核心訊息

Heart Test Laboratories, Inc., a company listed in the United States under the stock code HSCS.US, has been informed by the Securities and Exchange Commission (SEC) that its Registration Statement on Form S-1, filed on March 5, 2024, will not undergo review by the commission. The SEC's communication, dated March 11, 2024, was addressed to Andrew Simpson, the Chief Executive Officer of Heart Test Laboratories. The SEC's letter also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Additionally, the SEC reminded the company and its management of their responsibility to ensure the accuracy and adequacy of their disclosures, regardless of the SEC's level of review or lack thereof. For further inquiries, the SEC has provided contact information for Benjamin Richie.
Heart Test Laboratories, Inc., a company listed in the United States under the stock code HSCS.US, has been informed by the Securities and Exchange Commission (SEC) that its Registration Statement on Form S-1, filed on March 5, 2024, will not undergo review by the commission. The SEC's communication, dated March 11, 2024, was addressed to Andrew Simpson, the Chief Executive Officer of Heart Test Laboratories. The SEC's letter also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Additionally, the SEC reminded the company and its management of their responsibility to ensure the accuracy and adequacy of their disclosures, regardless of the SEC's level of review or lack thereof. For further inquiries, the SEC has provided contact information for Benjamin Richie.
美國證券交易委員會(SEC)已通知Heart Test Laboratories, Inc.,一家在美國上市的公司,股票代碼爲HSCS.US。,該公司於2024年3月5日提交的S-1表格註冊聲明將不接受該委員會的審查。美國證券交易委員會於2024年3月11日發給心臟測試實驗室首席執行官安德魯·辛普森的來文。美國證券交易委員會的信中還提到了與加快註冊程序的請求有關的第460和461條。此外,美國證券交易委員會提醒該公司及其管理層,無論美國證券交易委員會的審查水平如何,他們都有責任確保披露的準確性和充分性。爲了進一步調查,美國證券交易委員會提供了本傑明·裏奇的聯繫信息。
美國證券交易委員會(SEC)已通知Heart Test Laboratories, Inc.,一家在美國上市的公司,股票代碼爲HSCS.US。,該公司於2024年3月5日提交的S-1表格註冊聲明將不接受該委員會的審查。美國證券交易委員會於2024年3月11日發給心臟測試實驗室首席執行官安德魯·辛普森的來文。美國證券交易委員會的信中還提到了與加快註冊程序的請求有關的第460和461條。此外,美國證券交易委員會提醒該公司及其管理層,無論美國證券交易委員會的審查水平如何,他們都有責任確保披露的準確性和充分性。爲了進一步調查,美國證券交易委員會提供了本傑明·裏奇的聯繫信息。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息